These findings demonstrate that the METTL3–DLG2–Hippo/YAP axis is a critical regulatory cascade driving malignant progression in CC, providing a novel theoretical basis and potential therapeutic strategies for targeting METTL3 or activating DLG2 to restore the tumor-suppressive function of the Hippo pathway. The gene discussed is METTL3; the disease is cholangiocarcinoma.